by: Russell Falcon (KXAN) — After a recent resurgence in several states, health officials are warning residents to be aware of a dangerous of an unauthorized “treatment” for COVID-19 — often being taken with dangerous consequences. We know Texans are feeling the impact of the coronavirus in ways unlike any crisis in the state’s history. That’s...
by Barcelona Institute for Global Health SAINT Research team. Credit: ISGlobal/Clínica Universidad de Navarra. A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19, which in turn could help reduce viral transmission. The study, which is part of the SAINT project and has been led by...
By Dr. Sanchari Sinha Dutta, Ph.D. Jan 11 2021 A double-blind, randomized, placebo-controlled clinical trial conducted at the All India Institute of Medical Sciences, India, has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of coronavirus disease 2019 (COVID-19) patients. The study is currently available on the medRxiv* preprint server. Study: Ivermectin as a...
By Erin Michael Numerous studies have provided evidence supporting the use of ivermectin to prevent and treat COVID-19, according to the Frontline COVID-19 Critical Care Alliance. Paul Marik, MD, FCCM, FCCP, founder of the alliance and a professor and chief of the division of pulmonary and critical care medicine at Eastern Virginia Medical School, said that...
Since the onset of the disease, more than 40.5 million people have been diagnosed with COVID-19 and nearly 1.2 million people have died (October 21, 2020). There is no complete understanding of the pathogenesis of SARS-CoV-2 infection and to this day there is no specific therapy or vaccine available. Thus, patient care is based on...
A group of experts led by ISGlobal defines a clear pathway for evaluating and implementing ivermectin as a complementary vector control tool BARCELONA INSTITUTE FOR GLOBAL HEALTH (ISGLOBAL) A group of experts led by Regina Rabinovich and Carlos Chaccour from the Barcelona Institute for Global Health (ISGlobal) has published a roadmap to evaluate – and...
